Element Capital Management LLC Purchases Shares of 12,962 Danaher Corporation $DHR

Key Points

• Element Capital Management LLC has invested approximately $2.66 million in Danaher Corporation by purchasing 12,962 shares during the first quarter.
• Danaher Corporation reported a net margin of 14.21% and a revenue of $5.94 billion for the last quarter, exceeding analyst estimates.
• The stock currently holds an average rating of "Moderate Buy" with an average target price of $247.61 among analysts.

Element Capital Management LLC acquired a new position in shares of Danaher Corporation (NYSE:DHR - Free Report) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 12,962 shares of the conglomerate's stock, valued at approximately $2,657,000.

A number of other institutional investors have also added to or reduced their stakes in DHR. GHP Investment Advisors Inc. lifted its position in Danaher by 396.0% during the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock worth $25,000 after acquiring an additional 99 shares during the last quarter. Heck Capital Advisors LLC bought a new position in Danaher in the 4th quarter valued at approximately $27,000. Sierra Ocean LLC grew its position in Danaher by 116.9% during the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock worth $29,000 after acquiring an additional 76 shares during the last quarter. Smallwood Wealth Investment Management LLC acquired a new stake in Danaher during the 1st quarter worth approximately $31,000. Finally, Dunhill Financial LLC raised its position in Danaher by 68.4% during the 1st quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock worth $34,000 after purchasing an additional 67 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts have recently commented on DHR shares. UBS Group reduced their price objective on shares of Danaher from $240.00 to $225.00 and set a "buy" rating on the stock in a research note on Wednesday, July 23rd. Royal Bank Of Canada reissued an "outperform" rating and set a $250.00 target price on shares of Danaher in a research report on Wednesday, April 23rd. Evercore ISI lowered their price target on Danaher from $230.00 to $226.00 and set an "outperform" rating for the company in a research report on Tuesday, July 8th. Wells Fargo & Company decreased their price target on Danaher from $210.00 to $205.00 and set an "equal weight" rating for the company in a research report on Wednesday, July 23rd. Finally, HSBC reduced their target price on shares of Danaher from $270.00 to $240.00 in a research report on Friday, April 25th. Seventeen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $247.61.

Danaher Trading Down 2.0%

Shares of NYSE DHR traded down $4.2720 during trading hours on Thursday, hitting $207.1280. The company's stock had a trading volume of 794,099 shares, compared to its average volume of 4,213,259. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $279.90. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62. The business has a 50-day simple moving average of $200.46 and a 200-day simple moving average of $199.62. The stock has a market cap of $148.31 billion, a price-to-earnings ratio of 44.09, a P/E/G ratio of 2.96 and a beta of 0.73.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, topping the consensus estimate of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The business had revenue of $5.94 billion during the quarter, compared to analyst estimates of $5.83 billion. During the same period last year, the business posted $1.72 earnings per share. Danaher's quarterly revenue was up 3.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, analysts anticipate that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.